Cellcyte Genetics Corp. Debt Instrument, Convertible, Beneficial Conversion Feature
Cellcyte Genetics Corp. reported Debt Instrument, Convertible, Beneficial Conversion Feature of $20.00 thousand for the 12-month period ending 2009-12-31, per its 10-K filed 2014-04-15.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature · last filed 2014-04-15
- Cellcyte Genetics Corp. debt instrument, convertible, beneficial conversion feature for fiscal 2009 was $20.00K, a 21.95% increase from fiscal 2008.
- Cellcyte Genetics Corp. debt instrument, convertible, beneficial conversion feature for fiscal 2008 was $16.40K.
| Period end | Debt Instrument, Convertible, Beneficial Conversion Feature 12 month |
|---|---|
| 2009-12-31 | $20.00K 10-K · filed 2014-04-15 |
| 2008-12-31 | $16.40K 10-K · filed 2014-04-15 |